Cargando…
How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis
Thousands of clinical trials all over the world were stopped, disrupted or delayed while countries grappled to contain the pandemic and research resources were redeployed. The long-term effects of the turbulence caused by the pandemic have yet to be fully understood, but it should already be clear t...
Autor principal: | Anderson, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288280/ https://www.ncbi.nlm.nih.gov/pubmed/34275327 http://dx.doi.org/10.4155/bio-2021-0107 |
Ejemplares similares
-
Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development
por: Wickremsinhe, Enaksha R, et al.
Publicado: (2021) -
PCR in bioanalysis /
Publicado: (1998) -
How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases
por: Kopp, Wolfgang
Publicado: (2019) -
Disruptive Innovation and Refractive IOLs: How the Game Will Change With Adjustable IOLs
por: Chang, David F.
Publicado: (2019) -
Remote Monitoring in Clinical Trials During the COVID‐19 Pandemic
por: Izmailova, Elena S., et al.
Publicado: (2020)